MedPath

Study of optimization of Helicobacter pylori eradication therapy in consideration of the PK / PD in chronic hemodialysis patients

Not Applicable
Conditions
Helicobacter pylori-associated chronic gastritis
Registration Number
JPRN-UMIN000014910
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

subjects with a history of H. pylori eradication therapy, a significant clinical illness (e.g. malignancy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success rate of eradication therapy Safety of eradication therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath